Hematopoietic stem cell transplant in patients with activated PI3K delta syndrome - 19/04/17
Doi : 10.1016/j.jaci.2016.09.040
Zohreh Nademi, PhD a, b 
, Mary A. Slatter, MD a, b, Christopher C. Dvorak, MD c, Benedicte Neven, PhD d, Alain Fischer, MD d, Felipe Suarez, MD e, Claire Booth, MD f, Kanchan Rao, MD g, Alexandra Laberko, MD h, Julia Rodina, MD h, Yves Bertrand, MD i, Sylwia Kołtan, MD j, Robert Dębski, MD j, Terence Flood, MD a, Mario Abinun, MD a, b, Andrew R. Gennery, MD a, b, Sophie Hambleton, DPhil a, b, Stephan Ehl, MD k, Andrew J. Cant, MD a, b
, Mary A. Slatter, MD a, b, Christopher C. Dvorak, MD c, Benedicte Neven, PhD d, Alain Fischer, MD d, Felipe Suarez, MD e, Claire Booth, MD f, Kanchan Rao, MD g, Alexandra Laberko, MD h, Julia Rodina, MD h, Yves Bertrand, MD i, Sylwia Kołtan, MD j, Robert Dębski, MD j, Terence Flood, MD a, Mario Abinun, MD a, b, Andrew R. Gennery, MD a, b, Sophie Hambleton, DPhil a, b, Stephan Ehl, MD k, Andrew J. Cant, MD a, b a Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
b Primary Immunodeficiency Group, Institute of Cellular Medicine, Newcastle upon Tyne University, Newcastle upon Tyne, United Kingdom
c Benioff Children's Hospital, University of California San Francisco, San Francisco, Calif
d Pediatric Hematology-Immunology and Rheumatology Unit, Necker-Enfants Malades University Hospital, Paris, France
e Department of Hematology, Necker-Enfants Malades University Hospital, Paris, France
f Department of Pediatric Immunology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
g Department of Bone Marrow Transplant, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
h Center for Pediatric Hematology, Oncology, Immunology, Moscow, Russia
i Institut d'Hématologie et d'Oncologie pédiatrique (Hospices Civils de Lyon) et Université Claude Bernard Lyon, Lyon, France
j Department of Pediatric, Hematology and Oncology, Collegium Medicum Bydgoszcz, Nicolaus Copernicus University, Toruń, Poland
k Center for Chronic Immunodeficiency, University of Freiburg Medical Center, Freiburg, Germany
| Disclosure of potential conflict of interest: C. C. Dvorak has received board membership from Jazz Pharmaceuticals and Chimerix, Inc. S. Ehl's institution has received a grant from BMBF. He has received consultancy fees from UCB, Novimmue, and Novartis; grants from UCB; and payment for lectures from Biotest and Baxalta. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2016
American Academy of Allergy, Asthma & Immunology. Tous droits réservés.
Vol 139 - N° 3
P. 1046-1049 - mars 2017 Retour au numéro
Article précédent
- Vedolizumab as a successful treatment of CTLA-4–associated autoimmune enterocolitis
- Alexander A. Navarini, Petr Hruz, Christoph T. Berger, Tie Zheng Hou, Charlotte Schwab, Annemarie Gabrysch, Rebecca Higgins, Natalie Frede, Barbara-Christina Padberg Sgier, Olle Kämpe, Anne-Valérie Burgener, Florian Marquardsen, Fabian Baldin, Marc Bigler, Anne Kistner, Annaise Jauch, Olivier Bignucolo, Benedikt Meyer, Fabian Meienberg, Matthias Mehling, Lukas T. Jeker, Ingmar Heijnen, Thomas D. Daikeler, Jan-Olaf Gebbers, Bodo Grimbacher, David M. Sansom, Raphael Jeker, Christoph Hess, Mike Recher
- B cells differentiate in human thymus and express AIRE
- Vincent Gies, Aurélien Guffroy, François Danion, Philippe Billaud, Céline Keime, Jean-Daniel Fauny, Sandrine Susini, Anne Soley, Thierry Martin, Jean-Louis Pasquali, Frédéric Gros, Isabelle André-Schmutz, Pauline Soulas-Sprauel, Anne-Sophie Korganow
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?